Head of the Leerink Center for Pharmacoeconomics, Melanie Whittington, PhD

Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech

The IP Policy Institute’s Joshua Kresh and Emily Michiko Morris

Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA

Head of Patient Engagement and Patient-Centered Innovation, Raven, RA Capital's healthcare incubator, Gunnar Esiason, MBA, MPH

Vice Chair of Research and Associate Professor, University of Utah, Joey Mattingly, PharmD, MBA, PhD

Chief Science Officer, National Pharmaceutical Council, Jon Campbell, PhD

Head of U.S. Public Affairs and Patient Advocacy, Oncology with Sanofi, Elizabeth Franklin, PhD, MSW

Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute, Kirsten Axelsen

Managing Director of Pharmagellan and Professor of the Practice at Tufts University, Frank S. David, MD, PhD

Author of the Cost Curve & the Principal and Founder of Reid Strategic, Brian Reid

Welcome to Perspectives by the Leerink Center for Pharmacoeconomics